Has Jules Winokur, MD received payments from drug or device companies?

Yes. Drug and device makers reported $187 in general payments to Jules Winokur, MD across 2 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jules Winokur, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jules Winokur, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jules Winokur, MD

Ophthalmology · Jamaica, NYNPI 1336261692

Payments from drug & device makers

$187in general payments, 2019–2025

Across 2 payments — averaging $93.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Rxsight Inc$113
Aerie Pharmaceuticals, Inc.$74

What the payments were for

Food & beverage$187100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Rxsight Inc	1	$113
Aerie Pharmaceuticals, Inc.	1	$74

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$187 in reported general payments places this provider in the 20th percentile of 1,587 ophthalmology providers in New York.

See all ophthalmology providers in New York →

Medicare billing

Part B allowed, 2024

$419,011

Medicare patients

937

Services billed

2,636

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MieboPerfluorohexyloctane/Pf	26	$20,093
Prednisolone Acetate	235	$14,863
XiidraLifitegrast	16	$12,957
Brimonidine Tartrate	21	$3,142
Loteprednol Etabonate	14	$2,885
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	13	$2,212
Ofloxacin	130	$2,206
Timolol Maleate	33	$1,463
Ketorolac Tromethamine	40	$1,306
Difluprednate	14	$1,041
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	27	$577
Vancomycin Hcl	14	$514
Latanoprost	43	$449
Doxycycline Hyclate	14	$412
ErythromycinErythromycin Base	31	$374

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Jamaica

Douglas JabsNew York$24.3M
David RubaltelliBrooklyn$8.9M
Philip FerroneGreat Neck$5.8M
Eric DonnenfeldGarden City$2.6M
Nathan RadcliffeNew York$2.4M
Glenn StollerRockville Centre$2.1M
Richard SpaideNew York$1.7M
Paul HartmanRochester$1.6M
Jason SlakterNew York$1.2M
David ChuNew York$1.2M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →